Breaking News
Investing Pro 0
Cyber Monday Deal: Up to 55% off CLAIM SALE

Strong Performances For European Pharma Biotech And Transportation

By IHS Markit (Chris Williamson)Market OverviewAug 11, 2017 05:23
uk.investing.com/analysis/strong-performances-for-european-pharma--biotech-and-transportation-200196644
Strong Performances For European Pharma Biotech And Transportation
By IHS Markit (Chris Williamson)   |  Aug 11, 2017 05:23
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
FRAG
+1.08%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SIGSI
0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

The IHS Markit Europe PMI Composite Output Index declined from 55.8 in June to a six-month low of 55.3 in July. However, despite the slight cooling, economic growth remained strong and among the highest for six years.

Europe Composite Manufacturing+Services
Europe Composite Manufacturing+Services

Beneath the headline number, detailed sector data suggested different trends across sectors and highlighted the best performers for July. Two particular sectors, pharmaceuticals and biotechnology and transportation, are currently gaining momentum and may attract more attention from investors in the near-term future. Companies in both sectors are experiencing positive developments, seeing their order books grow while keeping their profit margins under control.

Pharmaceuiticals & Biotehnology Sector
Pharmaceuiticals & Biotehnology Sector

Lift in output for Pharma and Biotech and Transportation

Pharmaceuticals and biotechnology companies indicated that growth of output held at the fastest for ten years in July. This recent boost is even more significant considering that the sector was in contraction just a year earlier.

Transportation also experienced a sharp rise in output in July. Growth was the second-highest for just under seven years, behind last November’s recent peak.

Transportation Sector
Transportation Sector

As an example of the upturn in the transportation sector, BBA Aviation (LON:BBA) in the UK recorded an improved profit performance during the first half of the year. In the half year ended June 30, the company made a pre-tax profit of $84.7m compared with a loss of $269m the year before. The same was true for Fraport AG (DE:FRAG) in Germany whose revenue advanced to €1.4b in H1, representing an increase of 10.7% year-on-year.

Order books back on the rise

The pick-up in output growth for the two sectors has been the result of an upward shift in momentum in new orders.

As indicated in the accompanying charts, the trend in new orders had been negative from the start of the second half of 2015 to mid-2016. Companies in both sectors had experienced a slowdown until July/August 2016, when pharmaceuticals and biotechnology was even indicating an outright contraction.

From that point, a rebound was initiated and a change in momentum occurred. Order books in both sectors improved significantly since and a continuous progression has been evident. We note that the turnaround appears to be sharper for pharmaceutical and biotechnology companies than in the transportation sector.

Negative trend from July-15 to July-16…

New Orders PMI Index
New Orders PMI Index

…but gaining momentum from Aug-16 to July-17

New Oreders PMI Index
New Oreders PMI Index

Early positive sign for margins

However, some risks remained during late-2016 and early-2017, as input prices rose at a sharp pace and therefore placed pressure on sector margins. The transportation sector appeared to be the more sensitive to the rise in costs.

During July, however, the risk eased significantly. Pharmaceuticals and biotechnology indicated stronger growth in output prices than for input costs for the first time in 12 months, and in the transportation sector the difference between input cost and output price inflation was the least marked for one-and-a-half years.

Pressure on margins eases in July

Output Prices minus input Prices PMI Index
Output Prices minus input Prices PMI Index

Disclaimer: The intellectual property rights to these data provided herein are owned by or licensed to Markit Economics Limited. Any unauthorised use, including but not limited to copying, distributing, transmitting or otherwise of any data appearing is not permitted without Markit’s prior consent. Markit shall not have any liability, duty or obligation for or relating to the content or information (“data”) contained herein, any errors, inaccuracies, omissions or delays in the data, or for any actions taken in reliance thereon.

In no event shall Markit be liable for any special, incidental, or consequential damages, arising out of the use of the data. Purchasing Managers' Index™ and PMI™ are either registered trademarks of Markit Economics Limited or licensed to Markit Economics Limited. Markit is a registered trade mark of Markit Group Limited.

Original post

Strong Performances For European Pharma Biotech And Transportation
 

Related Articles

Strong Performances For European Pharma Biotech And Transportation

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email